Today: 20 March 2026
Subscribe
Browse Category

NYSE:MCO 11 December 2025 - 9 March 2026

Dubai Real Estate Market Today: Supply Wave Looms as Analysts Flag Price Cooling Risk

Dubai Real Estate Market Today: Supply Wave Looms as Analysts Flag Price Cooling Risk

Moody’s forecasts about 180,000 new Dubai residential units will be completed between 2026 and 2028, likely slowing price growth. Brokers report deals are still closing, but more buyers are holding off. Foreign demand, especially from Indian buyers, continues to support the market. Dubai recorded AED 11.85 billion in real estate transactions last week, with 2,631 sales.
9 March 2026
··
S&P Global stock jumps into U.S. holiday weekend as AI fears linger; next week’s data loom

S&P Global stock jumps into U.S. holiday weekend as AI fears linger; next week’s data loom

S&P Global shares closed up 3.3% at $409.54 Friday, trading 4.7 million shares, more than double the 50-day average. The move follows a volatile month amid investor concerns over AI risks to data firms and a lower-than-expected 2026 profit forecast. The stock remains about 29% below its 52-week high. Key U.S. economic data and Fed minutes are due next week.
15 February 2026
····
CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave stock jumps 11% as Goldman starts coverage and Moody’s flags $3 trillion data-center boom

CoreWeave shares climbed 11% to $88.94 in late morning trading Monday after Goldman Sachs began coverage with a Neutral rating and $86 price target. Moody’s projected at least $3 trillion in data-center investment over five years, naming CoreWeave among six major U.S. operators. The Nasdaq 100 was little changed.
12 January 2026
·········
Moody’s Corporation (MCO) Stock: What Changed Since November 21, 2025 – Latest News, Forecasts and Outlook

Moody’s Corporation (MCO) Stock: What Changed Since November 21, 2025 – Latest News, Forecasts and Outlook

Moody’s shares rose from $479.65 on November 21 to about $486–$487 by December 11, after hitting $496.50 on December 5 before three straight days of losses. Trading volume spiked on December 10, with over 2.4 million shares exchanged. The stock remains about 8% below its February 52-week high. Q3 profit climbed to $646 million, up from $534 million a year earlier.
11 December 2025
··

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop